Publications by authors named "Birthe Lohmann"

Claim this Profile
I
Interferon-β sensitizes human glioblastoma cells to the cyclin-dependent kinase inhibitor, TG02.
Birthe Lohmann, Emilie Le Rhun, Manuela Silginer, Mirka Epskamp, Michael Weller

Oncol Lett· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferon-β exposure induces a fragile glioblastoma stem cell phenotype with a transcriptional profile of reduced migratory and MAPK pathway activity.
Birthe Lohmann, Manuela Silginer, Daniel Picard, Hannah Schneider, Marc Remke

Neurooncol Adv· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profound, durable and MGMT-independent sensitivity of glioblastoma cells to cyclin-dependent kinase inhibition.
Emilie Le Rhun, Caroline von Achenbach, Birthe Lohmann, Manuela Silginer, Hannah Schneider

Int J Cancer· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-associated and therapy-induced alterations in the cellular microenvironment of experimental gliomas.
Hannah Schneider, Birthe Lohmann, Hans-Georg Wirsching, Kathy Hasenbach, Elisabeth J Rushing

Oncotarget· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-17 impedes Schwann cell-mediated myelination.
Mark Stettner, Birthe Lohmann, Kathleen Wolffram, Jan-Philipp Weinberger, Thomas Dehmel

J Neuroinflammation· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis